Serotonin transporter binding is reduced in seasonal affective disorder following light therapy
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Objective: To investigate the effects of light therapy on serotonin transporter binding (5‐HTT BP ND), an index of 5‐HTT levels, in the anterior cingulate and prefrontal cortices (ACC and PFC) during winter in seasonal affective disorder (SAD). 5‐HTT BP ND fluctuates seasonally to a greater extent in SAD relative to health. We hypothesized that in SAD, 5‐HTT BP ND would be reduced in the ACC and PFC following light therapy. Methods: Eleven SAD participants underwent [11 C] DASB positron emission tomography (PET) scans to measure 5‐HTT BP ND before and after 2 weeks of daily morning light therapy. Results: The primary finding was a main effect of treatment on 5‐HTT BP ND in the ACC and PFC (repeated‐measures manova, F(2,9) = 6.82, P = 0.016). This effect was significant in the ACC (F(1,10) = 15.11 and P = 0.003, magnitude of decrease, 11.94%) and PFC (F(1,10) = 8.33, P = 0.016, magnitude of decrease, 9.13%). 5‐HTT BP ND also decreased in other regions assayed following light therapy (repeated‐measures manova, F(4,7) = 8.54, P = 0.028) including the hippocampus, ventral striatum, dorsal putamen, thalamus and midbrain (F(1,10) = 8.02–36.94, P < 0.0001–0.018; magnitude −8.83% to −16.74%). Conclusions: These results demonstrate that light therapy reaches an important therapeutic target in the treatment of SAD and provide a basis for improvement of this treatment via application of [11 C]DASB PET.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The neural basis of loss aversion in decision-making under risk
Tom, S. M., Fox, C. R., Trepel, C., & Poldrack, R. A. (2007) · Science · doi:10.1126/science.1134239 · Cited by 1,733 · cited 1×
“‘loss aversion’) whereas enhanced activity accompanies recall of positive life events (27, 28).”
BackgroundKapur, S., Zipursky, R., Jones, C., Remington, G., & Houle, S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.4.514 · Cited by 1,090
Self-citationTargeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic
Ressler, K. J., & Mayberg, H. S. (2007) · Nature Neuroscience · doi:10.1038/nn1944 · Cited by 1,007
Neural mechanisms mediating optimism bias
Sharot, T., Riccardi, A. M., Raio, C. M., & Phelps, E. A. (2007) · Nature · doi:10.1038/nature06280 · Cited by 659
Effect of sunlight and season on serotonin turnover in the brain
Lambert, G., Reid, C., Kaye, D., Jennings, G., & Esler, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11737-5 · Cited by 587
Light Therapy for Seasonal and Nonseasonal Depression: Efficacy, Protocol, Safety, and Side Effects
Terman, M., & Terman, J. S. (2005) · CNS Spectrums · doi:10.1017/s1092852900019611 · Cited by 546 · cited 1×
“Briefly, subjects were asked to sit approximately 30 cm in front the light box, which emitted broad-spectrum fluorescent white light at 10 000 lux for 30 min, the standard treatment dose for SAD (3, 37).”
Mawlawi, O., Martinez, D., Slifstein, M., Broft, A., Chatterjee, R., Hwang, D.-R., Huang, Y., Simpson, N., Ngo, K., Van Heertum, R., et al. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200109000-00002 · Cited by 525 · cited 1×
“When motion was visible, it was corrected using frame realignment with respect a reference frame characterized by a high signal-tonoise ratio (42).”
MethodMeyer, J. H., Wilson, A. A., Sagrati, S., Hussey, D., Carella, A., Potter, W. Z., Ginovart, N., Spencer, E. P., Cheok, A., & Houle, S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.826 · Cited by 517 · cited 3×
“A significant global reduction in 5-HTT BPND was observed following light therapy (repeated-measures MANOVA, F(4,7) = 8.”
MethodSelf-citationLiotti, M., Mayberg, H. S., McGinnis, S., Brannan, S. L., & Jerabek, P. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1830 · Cited by 331
Terman, M., Terman, J. S., & Ross, D. C. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.10.875 · Cited by 307 · cited 1×
“Applying the SIGH-SAD, treatment response was defined as a reduction of at least 50% compared to baseline with a score of less than or equal to 14 and remission was defined as a score less than or equal to eight (39).”
MethodLam, R. W., Levitt, A. J., Levitan, R. D., Michalak, E. E., Cheung, A. H., Morehouse, R., Ramasubbu, R., Yatham, L. N., & Tam, E. M. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.2235 · Cited by 275 · cited 1×
“As such, a key direction of future study would be to examine the effect of this treatment on 5-HTT BPND in psychiatric illnesses for which light therapy has been shown to have efficacy, such as in bipolar disorder or in unipolar MDD, and to compare the effects in non-seasonal healthy controls (66, 67).”
BackgroundSelf-citationCobb, J. A., O’Neill, K., Milner, J., Mahajan, G. J., Lawrence, T. J., May, W. L., Miguel-Hidalgo, J., Rajkowska, G., & Stockmeier, C. A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.12.044 · Cited by 254
Lam, R. W., Levitt, A. J., Levitan, R. D., Enns, M. W., Morehouse, R., Michalak, E. E., & Tam, E. M. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.5.805 · Cited by 232 · cited 4×
“Seasonal MDEs consistent with reports from literature (5, 68).”
BackgroundInfluentialSelf-citationMeyer, J. H., Wilson, A. A., Sagrati, S., Miler, L., Rusjan, P., Bloomfield, P. M., Clark, M., Sacher, J., Voineskos, A. N., & Houle, S. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.156 · Cited by 182 · cited 1×
“regions of a template MRI are transformed onto the individual MRI based on a series of transformations and deformations that matched the template image to the individual co-registered MRI, as well as segmentation of the individual MRI to select grey matter voxels as previously described (44, 45).”
MethodSelf-citationAmyloid-β 11 C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
Liu, E., Schmidt, M. E., Margolin, R., Sperling, R., Koeppe, R., Mason, N. S., Klunk, W. E., Mathis, C. A., Salloway, S., Fox, N. C., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001877 · Cited by 151 · cited 1×
“For example, the novel therapeutic bapineuzumab, a humanized monoclonal antibody against the b-amyloid (Ab) N-terminus, reduces the accumulation of amyloid more prominently in mild–moderate relative to severe Alzheimer’s disease, suggesting that the therapeutic might be best developed for an earlier phase of the illne…”
BackgroundSelf-citationLight therapy for bipolar disorder: a case series in women
Sit, D., Wisner, K. L., Hanusa, B. H., Stull, S., & Terman, M. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00451.x · Cited by 127
Light therapy in the treatment of patients with bipolar depression: A meta-analytic study
Tseng, P.-T., Chen, Y.-W., Tu, K.-Y., Chung, W., Wang, H.-Y., Wu, C.-K., & Lin, P.-Y. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.03.001 · Cited by 100 · cited 1×
“As such, a key direction of future study would be to examine the effect of this treatment on 5-HTT BPND in psychiatric illnesses for which light therapy has been shown to have efficacy, such as in bipolar disorder or in unipolar MDD, and to compare the effects in non-seasonal healthy controls (66, 67).”
BackgroundEffects of fluoxetine versus bright light in the treatment of seasonal affective disorder
RUHRMANN, S., KASPER, S., HAWELLEK, B., MARTINEZ, B., HÖFLICH, G., NICKELSEN, T., & MÖLLER, H.-J. (1998) · Psychological Medicine · doi:10.1017/s0033291798006813 · Cited by 83
Research works printed but not linked: 50
- 10.1001/archpsyc.1984.01790120076010 · DOI · Paper page
- 10.1001/archpsyc.1993.01820130019004 · DOI · Paper page
- Terman JS, 1990, Efficacy of brief, intense light exposure for treatment of winter depression, Psychopharmacol Bull, 26, 3
- 10.1001/archpsyc.55.10.890 · DOI · Paper page
- 10.1176/appi.ajp.158.11.1843 · DOI · Paper page
- 10.1016/S1474-4422(10)70043-0 · DOI · Paper page
- 10.1001/jamapsychiatry.2014.2427 · DOI · Paper page
- 10.1034/j.1600-0447.2000.101003176.x · DOI · Paper page
- 10.3109/07420528.2013.800091 · DOI · Paper page
- 10.1177/070674370304800413 · DOI
- Kasper S, 1989, Epidemiological findings of seasonal changes in mood and behavior. A telephone survey of Montgomery County, Maryland, Arch Gen Psychiatry, 146, 823
- 10.1523/JNEUROSCI.1953-10.2010 · DOI
- 10.3109/15622975.2011.630405 · DOI · Paper page
- 10.1001/archpsyc.65.9.1072 · DOI · Paper page
- 10.1016/j.biopsych.2009.11.027 · DOI
- 10.1007/s00259-008-1057-x · DOI
- Buchert R, 2006, Is correction for age necessary in SPECT or PET of the central serotonin transporter in young, healthy adults?, J Nucl Med, 47, 38
- 10.1038/npp.2016.54 · DOI
- 10.1093/brain/aww043 · DOI
- Mayberg HS, 1999, Reciprocal limbic‐cortical function and negative mood: converging PET findings in depression and normal sadness, Am J Psychiatry, 156, 675, 10.1176/ajp.156.5.675 · DOI · Paper page
- 10.1016/0306-4522(88)90282-5 · DOI · Paper page
- 10.1016/0006-8993(89)90511-8 · DOI · Paper page
- 10.1016/0006-3223(88)90198-9 · DOI · Paper page
- 10.1111/acps.12424 · DOI
- Rosenthal N, 1984, Seasonal pattern assessment questionnaire (SPAQ)
- Lam RW, 1999, Canadian consensus guidelines for the treatment of seasonal affective disorder
- Williams J, 1994, Structured interview guide for the Hamilton depression rating scale – seasonal affective disorder version (SIGH‐SAD)
- 10.1097/00004647-200111000-00010 · DOI · Paper page
- 10.1021/jm000079i · DOI · Paper page
- 10.1097/00004728-199207000-00024 · DOI · Paper page
- 10.1016/j.pscychresns.2006.01.011 · DOI · Paper page
- 10.1097/01.WCB.0000085441.37552.CA · DOI · Paper page
- 10.1097/00004647-199609000-00008 · DOI · Paper page
- 10.1097/01.WCB.0000033967.83623.34 · doi:10.1097/01.wcb.0000033967.83623.34 · Paper page
- 10.1016/j.jpsychires.2012.10.020 · DOI · Paper page
- 10.3109/15622975.2011.583940 · DOI · Paper page
- 10.1007/978-3-7643-8561-3_3 · DOI · Paper page
- 10.1016/0006-8993(94)91435-4 · DOI
- 10.1038/npp.2013.35 · DOI
- 10.1053/smrv.2001.0174 · DOI · Paper page
- 10.1016/j.pnpbp.2004.11.015 · DOI
- 10.1016/0014-2999(80)90403-3 · DOI
- 10.1007/s00213-002-1166-3 · DOI · Paper page
- 10.1038/clpt.2011.285 · DOI · Paper page
- 10.1017/S1461145711001945 · DOI · Paper page
- 10.1016/j.biopsych.2005.04.038 · DOI
- 10.1002/syn.20105 · DOI
- 10.1111/acps.12569 · doi:10.1111/acps.12569
- 10.1002/syn.21605 · DOI
- 10.1016/j.biopsych.2005.07.021 · DOI
Cited by
Seasonal variations in cardiovascular disease
Stewart, S., Keates, A. K., Redfern, A., & McMurray, J. J. V. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.76 · Cited by 328
Pjrek, E., Friedrich, M.-E., Cambioli, L., Dold, M., Jäger, F., Komorowski, A., Lanzenberger, R., Kasper, S., & Winkler, D. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000502891 · Cited by 136
Biological rhythms and chronotherapeutics in depression
Geoffroy, P. A., & Palagini, L. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110158 · Cited by 127
Lam, R. W., Teng, M. Y., Jung, Y.-E., Evans, V. C., Gottlieb, J. F., Chakrabarty, T., Michalak, E. E., Murphy, J. K., Yatham, L. N., & Sit, D. K. (2020) · The Canadian Journal of Psychiatry · doi:10.1177/0706743719892471 · Cited by 70
Use of “Lights” for Bipolar Depression
Sit, D., & Haigh, S. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1025-0 · Cited by 37
Metadata
- Authors
- Tyrer, A. E., Levitan, R. D., Houle, S., Wilson, A. A., Nobrega, J. N., Rusjan, P. M., & Meyer, J. H.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2016-08-24
- Volume
- 134
- Issue
- 5
- Pages
- 410-419
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W2515513600
- Cited by
- 44
- References
- 18
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Funders
- Canadian Institutes of Health Research (RN158849 – 274056)
- Fondation Brain Canada
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.